Choline: The Brain Nutrient Most People Are Missing

TL;DR: Choline is an essential nutrient that most adults do not consume in adequate amounts. It is required for acetylcholine synthesis (the neurotransmitter central to memory and attention), structural integrity of every cell membrane in your brain, and critical methylation reactions. Eggs are the single best common food source. Among supplements, citicoline and alpha-GPC deliver choline to the brain more efficiently than choline bitartrate. Pregnant women, vegans, older adults, and APOE4 carriers have elevated needs. The old advice to limit eggs over cholesterol fears has been largely overturned by modern evidence.

Introduction

If there is a nutrient that deserves more attention than it gets, choline is a strong candidate. Officially recognized as an essential nutrient by the Institute of Medicine in 1998, choline plays foundational roles in brain chemistry, cellular structure, and gene expression. Without adequate choline, your brain cannot produce enough acetylcholine — the neurotransmitter most directly associated with memory formation, sustained attention, and learning. Your neurons cannot maintain the structural integrity of their membranes. And dozens of methylation-dependent processes, from DNA repair to neurotransmitter metabolism, begin to falter.

Despite all of this, the vast majority of adults in the United States and Europe do not meet the Adequate Intake (AI) for choline. National Health and Nutrition Examination Survey (NHANES) data analyzed by Zeisel and da Costa (2009) revealed that roughly 90 percent of Americans fall short of the recommended intake. This is not a fringe deficiency — it is a population-wide shortfall hiding in plain sight.

The reasons are straightforward. Choline is concentrated in foods that many people have been told to limit or avoid — especially eggs and liver. Decades of misguided dietary advice linking egg consumption to cardiovascular disease drove many health-conscious individuals away from what happens to be the most accessible, affordable, and nutrient-dense choline source available. At the same time, choline has never enjoyed the public awareness that surrounds nutrients like vitamin D, omega-3 fatty acids, or iron.

This article covers what choline does in the brain, how common inadequacy really is, the best food sources, how supplement forms compare, and who should be paying the closest attention to their intake.

What Choline Does in the Brain

Acetylcholine Synthesis

Choline’s most celebrated role in neuroscience is as the direct precursor to acetylcholine, a neurotransmitter with outsized importance for cognitive function. Acetylcholine is the primary signaling molecule in the cholinergic system — a network of neural pathways that governs memory encoding, attentional focus, learning speed, and the ability to filter relevant information from noise.

The synthesis is straightforward: the enzyme choline acetyltransferase combines choline with acetyl-CoA to produce acetylcholine. When circulating choline is insufficient, the brain has a limited ability to compensate. Acetylcholine production drops, and the cognitive functions it supports begin to degrade. This is not a theoretical concern — it is the biochemical reality underlying age-related memory decline and, in its most extreme form, Alzheimer’s disease, where cholinergic neurons are among the first to degenerate.

It is worth noting that every major class of drugs currently approved for Alzheimer’s disease (donepezil, rivastigmine, galantamine) works by inhibiting the enzyme that breaks down acetylcholine, effectively trying to squeeze more signaling out of whatever acetylcholine the brain can still produce. Ensuring adequate substrate supply through choline intake is the upstream side of the same equation.

Cell Membrane Integrity

Choline is a structural component of phosphatidylcholine, the most abundant phospholipid in mammalian cell membranes. Phosphatidylcholine accounts for roughly 40 to 50 percent of the total phospholipid mass in a typical cell membrane. In the brain, where membrane turnover is constant and membrane fluidity directly affects receptor function, ion channel behavior, and synaptic signaling, a steady supply of phosphatidylcholine is non-negotiable.

When dietary choline is scarce, the body can partially compensate through the PEMT (phosphatidylethanolamine N-methyltransferase) pathway, which converts phosphatidylethanolamine to phosphatidylcholine using methyl groups donated by S-adenosylmethionine (SAMe). However, this pathway is limited in capacity and places additional demands on methyl group donors — creating a cascade of metabolic trade-offs that can affect everything from homocysteine levels to epigenetic regulation.

Sphingomyelin, another choline-containing phospholipid, is a major component of the myelin sheath — the insulating layer that enables rapid electrical conduction along axons. Inadequate choline availability can compromise myelin integrity, potentially slowing neural processing speed.

Methylation and Epigenetic Regulation

Choline is one of the body’s key methyl donors. Through its oxidized metabolite betaine, choline contributes methyl groups to the folate-methionine cycle — the same metabolic hub that regenerates SAMe, the universal methyl donor used in over 200 enzymatic reactions. These methylation reactions include DNA methylation (which regulates gene expression), histone modification (which controls chromatin structure), and the synthesis of neurotransmitters such as serotonin, dopamine, and norepinephrine.

During fetal development, choline-dependent methylation is critical for establishing the epigenetic patterns that govern brain development, neural tube closure, and hippocampal formation. This is why choline requirements are sharply elevated during pregnancy — a point we will return to.

In adults, compromised methylation due to low choline intake can elevate homocysteine levels, a well-established risk factor for cardiovascular disease and an emerging marker of cognitive decline risk.

Prevalence of Inadequacy

The data on choline inadequacy are remarkably consistent and, frankly, alarming. Zeisel and da Costa published a landmark analysis in 2009 using NHANES data from 2003 to 2004, examining choline intake across the U.S. population. Their findings were unambiguous: only about 10 percent of the general population — and an even smaller fraction of certain subgroups — met the Adequate Intake for choline.

The current AI values, established by the National Academy of Medicine (formerly the Institute of Medicine), are 550 mg/day for adult men and 425 mg/day for adult women. During pregnancy, the recommendation rises to 450 mg/day, and during lactation to 550 mg/day. These are not ambitious targets. They represent the minimum intake judged sufficient to prevent overt organ dysfunction (particularly liver damage, which is one of the earliest clinical signs of choline deficiency).

Mean choline intake in the U.S. has been estimated at approximately 300 mg/day — well below the AI for both sexes. In the European Union, intakes are similar or lower, depending on the country and dietary pattern.

Several factors contribute to this widespread shortfall. Choline is not required on standard nutrition labels in most countries (the U.S. only began requiring it on updated Nutrition Facts panels in 2020, and compliance remains incomplete). Many dietary guidelines do not mention choline at all. And the foods richest in choline — eggs, liver, and other organ meats — are precisely the foods that decades of cholesterol-focused dietary advice told people to minimize.

The result is a population-wide gap between what the brain needs and what most people actually consume.

Best Food Sources of Choline

Not all foods contribute meaningful amounts of choline. Here are the top sources, ranked by choline content per typical serving:

1. Beef liver (3 oz / 85 g cooked): ~355 mg Liver is the single most concentrated food source of choline available. A single serving provides roughly 65 percent of the AI for men and over 80 percent for women. Liver also delivers high-quality protein, iron, vitamin A, folate, and B12. The challenge, of course, is that most people rarely eat it.

2. Eggs (2 large, whole): ~300 mg Eggs are the most practical choline source for the general population. Nearly all of the choline is in the yolk — egg whites contain negligible amounts. Two whole eggs at breakfast provide more than half the daily AI, along with complete protein, lutein, zeaxanthin, and vitamin D. The cholesterol concern that drove anti-egg messaging for decades has been substantially revised, as discussed below.

3. Soybeans (1 cup cooked): ~107 mg Soybeans are the best plant-based source of choline, though they deliver substantially less per serving than eggs or liver. Tofu, tempeh, and edamame all contribute meaningful amounts.

4. Chicken breast (3 oz / 85 g cooked): ~72 mg A modest but reliable source. Because chicken breast is consumed so frequently in many diets, it can contribute meaningful cumulative choline over the course of a day.

5. Cruciferous vegetables (1 cup cooked broccoli or Brussels sprouts): ~60–65 mg Broccoli, Brussels sprouts, and cauliflower are among the better vegetable sources. While the absolute amounts are moderate, these foods also provide sulforaphane, fiber, and other micronutrients with independent cognitive benefits.

6. Fish (3 oz / 85 g cooked salmon or cod): ~55–85 mg Fish contributes choline alongside omega-3 fatty acids, making it a doubly valuable food for brain health. Shrimp is notably high at roughly 115 mg per 3 oz serving.

7. Kidney beans and quinoa (1 cup cooked): ~45–55 mg Useful supplementary sources, particularly for plant-based diets, though they cannot independently close the gap for most people.

The practical takeaway from this ranking is that without eggs, liver, or targeted supplementation, reaching the AI for choline is genuinely difficult — especially on a vegan diet, where the best available sources (soybeans, cruciferous vegetables, quinoa) would need to be consumed in large quantities daily.

Supplement Forms Compared

For those who cannot or prefer not to meet choline needs through food alone, supplementation is a reasonable strategy. However, not all choline supplements are created equal. The three most common forms differ meaningfully in their bioavailability, brain penetration, and clinical evidence base.

Choline Bitartrate

Choline bitartrate is the simplest and cheapest form of supplemental choline. It provides choline bound to tartaric acid and is roughly 41 percent choline by weight. It is effective at raising circulating plasma choline levels and preventing the organ dysfunction (particularly fatty liver) associated with choline deficiency.

However, choline bitartrate does not cross the blood-brain barrier particularly well. While it supports peripheral choline needs and general methylation, it is not the optimal choice if the primary goal is enhancing brain acetylcholine levels or cognitive performance. Studies specifically examining cognitive outcomes with choline bitartrate have been limited and generally unimpressive.

Best use case: General nutritional insurance at low cost. Suitable for preventing deficiency-related health problems. Less suitable as a targeted nootropic.

Alpha-GPC (Alpha-Glycerophosphocholine)

Alpha-GPC is a choline compound that occurs naturally in the brain and is approximately 40 percent choline by weight. It crosses the blood-brain barrier more readily than choline bitartrate and has been shown to increase brain acetylcholine levels in both animal and human studies.

Clinical research on alpha-GPC has been most extensive in the context of age-related cognitive decline and dementia. A large Italian multicenter trial (De Jesus Moreno Moreno, 2003) found that 1200 mg/day of alpha-GPC produced consistent improvements on multiple cognitive assessment scales in patients with mild to moderate Alzheimer’s dementia over a six-month period. Smaller studies have shown benefits in healthy younger adults, particularly for attention and reaction time, though the evidence in healthy populations is less robust.

Alpha-GPC has also been studied for its ability to potentiate growth hormone release and enhance power output in athletes, though these applications are tangential to the cognitive discussion.

Best use case: Targeted cognitive support, particularly for older adults or those seeking to optimize acetylcholine-dependent functions (memory, focus, learning). Mid-range cost.

Citicoline (CDP-Choline)

Citicoline (cytidine diphosphate-choline) is a compound that, upon ingestion, is hydrolyzed into choline and cytidine. The cytidine is subsequently converted to uridine, which independently supports neuronal membrane synthesis and synaptic function. This dual mechanism — providing both a choline source and a uridine precursor — makes citicoline unique among choline supplements.

The clinical evidence for citicoline is arguably the strongest of the three forms. A systematic review by Fioravanti and Yanagi (2005, updated in the Cochrane Database) found positive effects on memory and behavior in elderly patients with cognitive deficits. More recent research, including a randomized controlled trial by McGlade et al. (2012) in healthy adolescent females, demonstrated improvements in attention and psychomotor speed with 250–500 mg/day of citicoline (as Cognizin). Alvarez-Sabin et al. (2013) showed that long-term citicoline treatment improved cognitive outcomes after ischemic stroke.

Citicoline also has a strong safety profile, with adverse effects in clinical trials being comparable to placebo.

Best use case: The most well-rounded option for brain-specific choline supplementation. Provides both choline and uridine, supports membrane synthesis and neurotransmitter production. Higher cost than choline bitartrate but justified by the evidence base.

Quick Comparison

Dosage Recommendations

For general nutritional adequacy, aim for a total choline intake (food plus supplements) of at least 550 mg/day for men and 425 mg/day for women. These are the Adequate Intake values established by the National Academy of Medicine.

For targeted cognitive support through supplementation:

• Citicoline: 250–500 mg/day. This is the dose range used in most positive cognitive trials. Some studies have used up to 1000 mg/day in clinical populations without adverse effects.
• Alpha-GPC: 300–600 mg/day for general cognitive support. Clinical trials in dementia populations have used 1200 mg/day (typically divided into three doses of 400 mg).
• Choline bitartrate: 500–1000 mg/day if the goal is primarily nutritional adequacy rather than cognitive enhancement.

The Tolerable Upper Intake Level (UL) for choline is 3,500 mg/day for adults. At very high intakes (well above typical supplemental doses), choline can cause a fishy body odor, excessive sweating, gastrointestinal distress, and hypotension. These side effects are dose-dependent and reversible.

It is worth noting that choline needs interact with folate status. Folate and choline share overlapping metabolic roles in one-carbon metabolism, and adequate folate intake can partially compensate for low choline intake (and vice versa). However, this compensation is limited — the two nutrients are not fully interchangeable.

Who Needs More Choline

Pregnant and Lactating Women

Choline requirements increase substantially during pregnancy and lactation. The developing fetal brain has enormous demands for phosphatidylcholine (for membrane synthesis) and choline-dependent methylation (for epigenetic programming). The hippocampus — the brain region most critical for memory formation — is particularly sensitive to choline availability during fetal development.

Animal research, primarily from the laboratory of Steven Zeisel at the University of North Carolina, has consistently demonstrated that maternal choline supplementation during pregnancy enhances offspring memory and learning capacity, with effects persisting into adulthood. Human evidence is catching up: a randomized controlled trial by Caudill et al. (2018) found that maternal consumption of 930 mg/day of choline (roughly double the AI) during the third trimester significantly improved infant information processing speed at 4, 7, 10, and 13 months of age.

Despite this evidence, most prenatal vitamins contain little or no choline. This is a significant gap in prenatal nutrition that deserves far more attention than it currently receives.

Vegans and Vegetarians

Plant-based diets, while offering many health benefits, make it substantially harder to achieve adequate choline intake. The richest plant sources (soybeans, cruciferous vegetables, quinoa) contain far less choline per serving than eggs or liver. Without deliberate planning and likely supplementation, most vegans will fall well below the AI.

This is not an argument against plant-based diets — it is an argument for supplementation awareness. Choline should be on every vegan’s short list of nutrients to actively manage, alongside vitamin B12, omega-3 DHA, and vitamin D. For a broader look at optimising a plant-based diet for the brain, see our guide to vegan diet and brain health.

Older Adults

Aging is associated with reduced choline absorption, declining cholinergic neuron function, and increased vulnerability to the cognitive consequences of inadequate acetylcholine synthesis. Older adults are also more likely to be taking medications that interfere with cholinergic signaling (including many common antihistamines, bladder medications, and tricyclic antidepressants).

Ensuring adequate choline intake — ideally through a combination of eggs, fish, and targeted supplementation — is a practical and low-risk strategy for supporting cognitive function during aging.

APOE4 Carriers

The APOE4 allele, carried by approximately 25 percent of the population, is the strongest common genetic risk factor for late-onset Alzheimer’s disease. Emerging research suggests that APOE4 carriers may have altered choline and phospholipid metabolism, potentially increasing their choline requirements for optimal brain health.

A 2019 study by Yassine and colleagues found that APOE4 carriers had lower plasma levels of certain choline-containing phospholipids, and that these lower levels were associated with greater brain atrophy. While the research is still in its early stages — and no clinical trial has yet demonstrated that choline supplementation specifically reduces Alzheimer’s risk in APOE4 carriers — the mechanistic rationale and observational data are strong enough to warrant proactive attention to choline intake in this population.

The Cholesterol Myth Debunked: Why Eggs Deserve a Comeback

For decades, eggs were vilified as a cardiovascular hazard because of their cholesterol content. A single large egg yolk contains approximately 186 mg of dietary cholesterol, and beginning in the 1960s, dietary guidelines recommended limiting cholesterol intake to 300 mg/day — effectively capping egg consumption at one per day or fewer for many Americans.

The problem is that this recommendation was based on an oversimplified understanding of the relationship between dietary cholesterol and blood cholesterol. We now know that for the majority of people, dietary cholesterol has a relatively modest effect on serum cholesterol levels. The liver tightly regulates cholesterol synthesis, and when dietary intake increases, endogenous production decreases in a compensatory fashion. The minority of individuals who are “hyper-responders” to dietary cholesterol do see larger increases in blood lipids, but even in these individuals, the increase tends to affect both LDL and HDL proportionally, without clearly worsening the LDL-to-HDL ratio that is more predictive of cardiovascular risk.

The evidence has shifted substantially. The 2015-2020 Dietary Guidelines for Americans removed the 300 mg/day cholesterol cap, stating that “cholesterol is not a nutrient of concern for overconsumption.” A large meta-analysis by Shin et al. (2013) examining data from 17 prospective cohort studies found no significant association between egg consumption (up to one egg per day) and risk of coronary heart disease or stroke in the general population. A more recent and even larger pooled analysis from the Prospective Studies Collaboration reached similar conclusions.

Multiple prospective studies — including the Physicians’ Health Study and the Health Professionals Follow-up Study — have found no significant increase in cardiovascular risk with moderate egg consumption (up to 7 eggs per week) in healthy individuals. The Finnish Kuopio Ischaemic Heart Disease Risk Factor Study followed over 2,600 men for 22 years and found that neither egg nor cholesterol intake was associated with increased risk of dementia or Alzheimer’s disease. In fact, higher egg consumption was associated with better performance on certain cognitive tests.

The practical implication is straightforward: for most people, eating two to three eggs per day is a safe and highly effective strategy for meeting choline needs, while simultaneously providing high-quality protein, lutein and zeaxanthin (which support retinal and brain health), vitamin D, and B vitamins. Individuals with familial hypercholesterolemia or existing cardiovascular disease should consult their physician, but for the general population, the cholesterol-based fear of eggs is no longer supported by the weight of the evidence.

Practical Takeaway

Choline is not optional for brain health — it is structurally and biochemically required. Yet most adults are not getting enough, largely because of limited dietary awareness and decades of misguided messaging about eggs and cholesterol. Here is what to do about it:

1. Eat eggs regularly. Two to three whole eggs per day is a safe, affordable, and effective foundation for meeting choline needs. Do not discard the yolks — that is where virtually all the choline resides.

2. Include other choline-rich foods. Liver (even once per week), fish, soybeans, and cruciferous vegetables all contribute meaningfully. Build meals around these foods when possible.

3. If you supplement, choose wisely. Citicoline (250–500 mg/day) offers the best evidence for cognitive benefit. Alpha-GPC (300–600 mg/day) is a strong alternative. Choline bitartrate is adequate for preventing deficiency but is not the best choice for brain-specific goals.

4. Pay special attention if you are in a high-need group. Pregnant and lactating women, vegans, older adults, and APOE4 carriers should treat choline as a priority nutrient, not an afterthought.

5. Do not fear dietary cholesterol from whole foods. The evidence no longer supports restricting egg intake for cardiovascular reasons in healthy individuals. The brain benefits of choline-rich foods far outweigh the outdated cholesterol concern.

Frequently Asked Questions

Can you get enough choline from diet alone?

Yes, but it requires deliberate effort. If you eat two to three eggs daily and include other choline-containing foods (fish, poultry, soybeans, cruciferous vegetables), you can meet or exceed the Adequate Intake without supplements. However, national survey data show that most people do not eat this way. For vegans, meeting the AI through diet alone is extremely difficult without substantial daily soy intake, and supplementation is strongly recommended.

What are the symptoms of choline deficiency?

Clinically diagnosed choline deficiency is uncommon, but suboptimal intake is widespread. Overt deficiency manifests as fatty liver (hepatic steatosis), muscle damage, and elevated liver enzymes — the liver is often the first organ to show signs because it has high choline demands for lipoprotein assembly and fat export. Neurological symptoms of severe deficiency can include cognitive impairment and memory problems. More subtle, chronic inadequacy may contribute to elevated homocysteine, impaired methylation capacity, and suboptimal acetylcholine production — effects that are harder to detect clinically but may have meaningful long-term consequences for brain health.

Is it possible to take too much choline?

Yes. The Tolerable Upper Intake Level is 3,500 mg/day for adults. Exceeding this level can cause fishy body odor (due to the accumulation of trimethylamine), excessive sweating, gastrointestinal distress, low blood pressure, and, in extreme cases, liver toxicity. At the doses used in typical supplementation (250–1000 mg/day), these effects are essentially nonexistent. There has also been research interest in the relationship between choline, gut microbiota, and trimethylamine N-oxide (TMAO), a metabolite associated with cardiovascular risk in some observational studies. The clinical significance of TMAO from moderate choline intake remains debated, and the benefits of adequate choline intake are considered to outweigh this theoretical concern by most researchers in the field.

Is alpha-GPC or citicoline better for cognitive performance?

Both are effective, and head-to-head comparisons in well-designed human trials are limited. Citicoline has the advantage of providing uridine as an additional active metabolite, which supports neuronal membrane synthesis through an independent mechanism. The overall clinical evidence base is somewhat deeper for citicoline, particularly in aging and post-stroke populations. Alpha-GPC may produce a slightly more noticeable acute effect on acetylcholine levels and has some evidence for enhancing physical performance. For most people seeking cognitive support, either is a reasonable choice. If cost is a factor, alpha-GPC is generally slightly less expensive at equivalent choline-delivery doses.

Sources

• Zeisel, S. H., & da Costa, K. A. (2009). Choline: an essential nutrient for public health. Nutrition Reviews, 67(11), 615–623.

• Institute of Medicine. (1998). Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academies Press.

• Caudill, M. A., Strupp, B. J., Muscalu, L., Nevins, J. E. H., & Canfield, R. L. (2018). Maternal choline supplementation during the third trimester of pregnancy improves infant information processing speed: a randomized, double-blind, controlled feeding study. The FASEB Journal, 32(4), 2172–2180.

• De Jesus Moreno Moreno, M. (2003). Cognitive improvement in mild to moderate Alzheimer’s dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clinical Therapeutics, 25(1), 178–193.

• McGlade, E., Locatelli, A., Hardy, J., Kamiya, T., Morita, M., Morishita, K., … & Yurgelun-Todd, D. (2012). Improved attentional performance following citicoline administration in healthy adult women. Food and Nutrition Sciences, 3(6), 769–773.

• Fioravanti, M., & Yanagi, M. (2005). Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database of Systematic Reviews, (2), CD000269.

• Alvarez-Sabin, J., Ortega, G., Jacas, C., Santamarina, E., Maisterra, O., Riba, M. D., … & Roman, G. C. (2013). Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Cerebrovascular Diseases, 35(2), 146–154.

• Shin, J. Y., Xun, P., Nakamura, Y., & He, K. (2013). Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis. The American Journal of Clinical Nutrition, 98(1), 146–159.

• Yassine, H. N., Croteau, E., Rawat, V., Hiber, S., Cunnane, S. C., & Bhatt, D. L. (2019). APOE genotype, plasma phospholipids, and brain phospholipid metabolism. Current Opinion in Lipidology, 30(5), 372–378.

• U.S. Department of Health and Human Services & U.S. Department of Agriculture. (2015). 2015–2020 Dietary Guidelines for Americans. 8th Edition.

• Virtanen, J. K., Mursu, J., Tuomainen, T. P., Virtanen, H. E., & Voutilainen, S. (2015). Egg consumption and risk of incident type 2 diabetes in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. The American Journal of Clinical Nutrition, 101(5), 1088–1096.

• Poly, C., Massaro, J. M., Seshadri, S., Wolf, P. A., Cho, E., Krall, E., … & Au, R. (2011). The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort. The American Journal of Clinical Nutrition, 94(6), 1584–1591.